Merck, known as MSD outside of the United States and Canada, announced that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences (Blackstone) for the ...

Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE ...

Lepu Biopharma Co. Ltd. said Oct. 30 it won Chinese approval of a novel antibody-drug conjugate (ADC), Meiyouheng (becotatug ...

Simtra BioPharma Solutions is advancing a dual-continent expansion aimed at boosting capacity for sterile injectable drugs.

Lahore, Punjab , Nov. 04, 2025 (GLOBE NEWSWIRE) -- ZeeKnows, a digital PR and LLM SEO agency at the forefront of AI-driven search innovation, today announced that its founder and principal strategist, ...

The deal hands Blackstone a piece of the potential future sales of an antibody-drug conjugate that could soon challenge marketed medicines from AstraZeneca and Gilead.

Merck is currently evaluating Sac-TMT in 15 global late-stage trials spanning six tumor types, including breast, endometrial, and lung cancers. ・Separately, the company also said that it has now ...

The deadline for required immunizations for Muscogee County School District is technically July 31, but schools allow a ...

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and other diseases, today announced the publication online of Part 1 results from ...

Merck (MRK) stock is in focus as the company secures $700M from Blackstone to advance cancer therapy sacituzumab tirumotecan ...